secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001104659-23-084851
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.01, 5.06, 3.02, 3.03, 5.03, 4.01, 5.01, 5.02, 5.05, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma (f/k/a Priveterra) closes business combination; ~37.2M shares outstanding
--------------------------------------------------------------------------------

- 1,445,112 shares redeemed at ~$10.63/share ($21.29M); remaining $5.92M trust used to fund deal.
- Old AEON shareholders received ~2.328 AEON shares per Old AEON share; Sponsor 6.9M shares (3.45M unvested).
- $40M interim notes converted into 5,797,611 shares; $7M PIPE for 1M shares at $7.00 per share.
- Forward purchase agreements with ACM ARRT J and Polar for up to 7.5M shares; FPA funding PIPE of 6.275M shares.
- Common stock and warrants began trading on NYSE American on July 24, 2023 under AEON and AEON WS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000110465923084851/0001104659-23-084851-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000110465923084851/tm2314948d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-084851

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer